491 related articles for article (PubMed ID: 31801262)
1. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers.
Mbese Z; Khwaza V; Aderibigbe BA
Molecules; 2019 Nov; 24(23):. PubMed ID: 31801262
[TBL] [Abstract][Full Text] [Related]
2. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive and chemotherapeutic potential of curcumin in breast cancer.
Sinha D; Biswas J; Sung B; Aggarwal BB; Bishayee A
Curr Drug Targets; 2012 Dec; 13(14):1799-819. PubMed ID: 23140290
[TBL] [Abstract][Full Text] [Related]
4. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway.
Teiten MH; Gaascht F; Cronauer M; Henry E; Dicato M; Diederich M
Int J Oncol; 2011 Mar; 38(3):603-11. PubMed ID: 21240460
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of curcumin and its semisynthetic analogues in prostate cancer prevention and treatment.
Jordan BC; Mock CD; Thilagavathi R; Selvam C
Life Sci; 2016 May; 152():135-44. PubMed ID: 27018446
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
[TBL] [Abstract][Full Text] [Related]
8. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
9. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
10. Curcumin and its formulations: potential anti-cancer agents.
Ji JL; Huang XF; Zhu HL
Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
[TBL] [Abstract][Full Text] [Related]
11. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
12. Carnosic acid inhibits the growth of ER-negative human breast cancer cells and synergizes with curcumin.
Einbond LS; Wu HA; Kashiwazaki R; He K; Roller M; Su T; Wang X; Goldsberry S
Fitoterapia; 2012 Oct; 83(7):1160-8. PubMed ID: 22828666
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptosis and cell cycle arrest via the activation of reactive oxygen species-independent mitochondrial apoptotic pathway in Smad4 and p53 mutated colon adenocarcinoma HT29 cells.
Agarwal A; Kasinathan A; Ganesan R; Balasubramanian A; Bhaskaran J; Suresh S; Srinivasan R; Aravind KB; Sivalingam N
Nutr Res; 2018 Mar; 51():67-81. PubMed ID: 29673545
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on new synthetic curcumin analogs and their potential anticancer properties.
Vyas A; Dandawate P; Padhye S; Ahmad A; Sarkar F
Curr Pharm Des; 2013; 19(11):2047-69. PubMed ID: 23116312
[TBL] [Abstract][Full Text] [Related]
15. Application of curcumin and its derivatives in tumor multidrug resistance.
Xu T; Guo P; He Y; Pi C; Wang Y; Feng X; Hou Y; Jiang Q; Zhao L; Wei Y
Phytother Res; 2020 Oct; 34(10):2438-2458. PubMed ID: 32255545
[TBL] [Abstract][Full Text] [Related]
16. An Ethanol Extract of Hawaiian Turmeric: Extensive In Vitro Anticancer Activity Against Human Colon Cancer Cells.
Dimas K; Tsimplouli C; Houchen C; Pantazis P; Sakellaridis N; Tsangaris GT; Anastasiadou E; Ramanujam RP
Altern Ther Health Med; 2015; 21 Suppl 2():46-54. PubMed ID: 26308760
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs.
Ke CS; Liu HS; Yen CH; Huang GC; Cheng HC; Huang CY; Su CL
J Nutr Biochem; 2014 May; 25(5):526-39. PubMed ID: 24613085
[TBL] [Abstract][Full Text] [Related]
18. Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review.
Sultana S; Munir N; Mahmood Z; Riaz M; Akram M; Rebezov M; Kuderinova N; Moldabayeva Z; Shariati MA; Rauf A; Rengasamy KRR
Biomed Pharmacother; 2021 Mar; 135():111078. PubMed ID: 33433356
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics.
Parashar K; Sood S; Mehaidli A; Curran C; Vegh C; Nguyen C; Pignanelli C; Wu J; Liang G; Wang Y; Pandey S
Molecules; 2019 Jul; 24(13):. PubMed ID: 31284561
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the TPA-induced invasion through inhibition of PKCα-dependent MMP-expression in MCF-7 human breast cancer cells.
Kim JM; Noh EM; Kwon KB; Kim JS; You YO; Hwang JK; Hwang BM; Kim BS; Lee SH; Lee SJ; Jung SH; Youn HJ; Lee YR
Phytomedicine; 2012 Sep; 19(12):1085-92. PubMed ID: 22921746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
